The defense mechanism of the gastrointestinal mucosa against aggressive factors, such as hydrochloric acid, bile acid and non-steroidal anti-inflammatory drugs, mainly consists of functional, humoral and neuronal factors. Mucus-alkaline secretion, mucosal microcirculation, and motility act as functional factors, while prostaglandins and nitric oxide act as humoral factors, and capsaicin sensitive sensory neurons act as neuronal factors. All the above factors are known to contribute to mucosal protection. In recent years, heat shock proteins (HSPs), to include HSP70, have been implicated to be an additional factor utilized for the defense mechanisms of the gastrointestinal mucosa at the intracellular level. The expression of HSP70 and HSP47 markedly changes during the development and healing of chronic gastric ulcers in rats. It was revealed that HSC70 (a constitutive form of HSP70) is coprecipitated with cyclooxygenase-1 and the neuronal form of nitric oxide synthase after treatment with a mild irritant (20% ethanol). A positive relationship between enhanced interaction of HSC70 with either cyclooxygenase-1 or nitric oxide synthase and mucosal protection against a strong irritant (100% ethanol) was observed. It was concluded that HSPs might contribute to mucosal defense mechanisms and ulcer healing, most probably through protecting key enzymes related to cytoprotection.
INTRODUCTION
Since the discovery of hydrochloric acid and pepsin in the stomach, the question "Why does the stomach not digest itself?" has persisted. Furthermore, it might also be asked "How does the gastric mucosa preserve its normal integrity against noxious materials that are secreted?" Following the painstaking efforts of various investigators, a part of the mechanism by which the stomach is able to maintain integrity under such harmful conditions is now understood. In addition to noxious gastric juices, a pathogenic bacteria was also discovered in the stomach, i.e., Helicobacter pylori (H. pylori). Accordingly, the question "How does the stomach resist against pathogenic bacteria?" must also be posed.
Recent advances in molecular biology have demonstrated that most cells are able to alter their metabolism and function by modulating protein synthesis at both transcriptional 1) and translational levels.
2) In response to environmental or physiological stress, such as heat, ethanol, heavy metals, or amino acid analogues, cells increase synthesis of intracellular proteins called heat shock proteins (HSPs) or stress proteins. [3] [4] [5] [6] [7] Certain HSPs are expressed under non-stressful conditions and play an important role in the maintenance of normal cell integrity. One such HSP function is represented by its role as a "molecular chaperone," folding polypeptides into mature tertiary structures. [8] [9] [10] In addition, HSPs are also considered to improve cellular recovery both by refolding partially damaged functional proteins and by increasing delivery of precursor proteins to important organelles, such as mitochondria. [11] [12] [13] HSPs are classified into several families according to their apparent molecular weights and respective inducers. Since the name of each HSP is derived from respective molecular weights following SDS-polyacrylamide electrophoresis, much confusion resulted from the use of different gel systems by different investigators. In this review, the naming system was simplified, i.e. HSP72→HSP70, HSP73→HSC
(heat shock cognate protein) 70 . Major HSPs expressed in mammalian cells are listed in Table 1 .
In this review, current ideas regarding gastrointestinal mucosa defense mechanisms are surveyed. In addition, the potential participation of several HSPs in acute mucosal damage and chronic gastric ulcers induced in animals is discussed as another intracellular defense mechanism.
DEFENSE MECHANISMS OF THE GASTRIC MUCOSA

2-1. Gastric Mucosal Barrier
In a series of reports published during the late 1960s, 14, 15) Davenport proposed a new model for the defense mechanism of the stomach, i.e., a "gastric mucosal barrier." Such a term implies that the gastric mucosa has a special barrier against noxious agents, such as aspirin, ethanol, or bile. When the barrier is broken by the above materials, the gastric mucosa then allows a back diffusion of gastric acid into the mucosal cells, leading to the mucosal damage. 15, 16) It must be noted that the word "barrier" was not morphologically defined at that time. The development of potent antisecretory drugs, such as histamine H2-receptor antagonists and gastric proton pump inhibitors, resulted in the realization that sodium bicarbonate is secreted from surface epithelial cells into the gastric cavity. Flemstrom et al. 17, 18) provided evidence that sodium bicarbonate secreted from surface epithelial cells and incorporated into the mucus layer might play a role in the mucosal barrier against gastric acid and other noxious substances that are ingested. As a matter of fact, it was revealed that the mucus layer has a pH gradient, i.e., the pH in the luminal side is around 1-2, while the pH at the bottom of the mucus (close to the surface epithelial cells) is 7.0. 19) Consequently, the surface epithelial cells are able to maintain their integrity despite an acidic milieu.
In addition, Lichtenberger et al. 20) elegantly demonstrated the presence of a phospholipid layer on the gastric mucosal surface using a contact angle method. Upon disruption of the phospholipid layer by aspirin or ethanol, gastric mucosal damage ensued. Based upon such findings, it was proposed that the phospholipid layer covering the mucosal surface might prevent noxious materials, to include ionized protons, from directly contacting the epithelial cells. Indeed, Lichtenberger 21) subsequently demonstrated that substances that include a high amount of phospholipid are capable to protect gastric mucosa against exogenously administered necrotizing substances.
2-2. Cytoprotection
In 1979, in an epoch-making study, Robert et al. 22) found an interesting phenomenon in regards to the pharmacology of prostaglandins (PGs), terming the phenomenon "cytoprotection."
The original concept of cytoprotection was based upon experiments performed on rats. Robert 22) proposed that PGs applied to gastric mucosa at a dose many times smaller than a dose that would affect gastric acid secretion protected the gastric mucosa against necrotizing substances, such as 100% ethanol, 0.6 M HCl, 0.2 M NaOH, 25% NaCl, or even boiling water. Such necrotizing agents are considered to be strong irritants. After the concept of cytoprotection was proposed, many investigators performed various studies examining the mechanism of such protection, which led to the development of cytoprotective drugs.
2-3. Adaptive Cytoprotection
Following the discovery of cytoprotection by examining the effects of exogenously administered PGs against strong necrotizing materials, Robert et al. 23) proposed another concept labeled "adaptive cytoprotection." This phenomenon appears to further the understanding of mucosal resistance mechanisms against harmful materials that were ingested into a stomach. The concept is founded upon observations that pretreatment with a low concentration of necrotizing materials, such as 20% ethanol, 20 mM taurocholate, 0.2 M HCl, 0.02 M NaOH, or 5% NaCl, protects the gastric mucosa against strong irritants. 23) Such substances that possess no necrotizing effect on gastric mucosa in and of themselves were called "mild irritants." Indeed, Robert found that the gastric mucosa was not damaged, despite the administration of 100% ethanol, when the mucosa was preliminarily treated with a mild irritant such as 20% ethanol. Administration of the same substance was not necessary to induce such a phenomenon, i.e., pretreatment with 20% ethanol could protect the mucosa against subsequent administration with another strong irritant, such as 0.6 M HCl, 0.25 M NaOH, or boiling water. Similarly, pretreatment with 0.2 M HCl protects the gastric mucosa against 0.6 M HCl or 100% ethanol. The underlying mechanism is known to involve endogenous PGs, as pretreatment with indomethacin attenuates such adaptive cytoprotection.
2-4. The Mechanism of Cytoprotection
In general, defensive mechanisms of the gastric mucosa against aggressive factors, such as hydrochloric acid, bile, non-steroidal anti-inflammatory drugs, or various stresses, mainly consists of functional, humoral, and neuronal factors. Mucus-alkaline secretions, 24, 25) a phospholipid layer, 20) microcirculation 26) and motility 27) act as functional factors, while PGs and nitric oxide (NO) act as humoral factors, 22, 28, 29) and capsaicin sensitive sensory neurons 30, 31) act as neuronal factors. 2-4-1. Functional Factors It has also been suggested that secreted bicarbonate from the gastrointestinal mucosa forms a mucus-bicarbonate barrier in the stomach, neutralizing the acid from the gastric mucosa in the duodenum, and consequently contributing to mucosal protection. 25) It is well known that there is a positive relationship between gastric mucosal blood flow and mucosal protection. 26) It has been reported that an increase in gastric mucosal blood flow is observed after treatment with mild irritants 32) and that inhibition of the increase in mucosal blood flow by indomethacin, N G -nitro-L-arginine methyl ester (L-NAME), or sensory ablation, aggravates mucosal lesions resulting from strong irritants. [32] [33] [34] Based on such evidence, the mucosal microcirculation is believed to play an important role in mucosal protection by removing back-diffused acid in the mucosa and transporting humoral factors involved in cytoprotection into the epithelial cells. It has been suggested that gastric motility changes play a role in the development and prevention of gastric lesions following both stress and administration of nonsteroidal anti-inflammatory drugs. 26, 35) Such lesions ap- pear as elongated bands along the long axis of the stomach, similar to bands observed in the stomach following exposure to necrotizing agents. Based upon previous studies by Mersereau and co-workers 35) and Takeuchi and Nobuhara, 36) it is postulated that inhibited gastric motility might induce flattening of the mucosal folds, decreasing the susceptibility of mucosal folds to the corrosive action of irritants, which leads to mucosal protection. The above clearly indicates that the importance of functional mucosal defensive factors, such as mucus/alkaline secretion, microcirculation, and motility have been documented. It is also well known that such factors are regulated by humoral factors for cytoprotection, such as PGs and NO, and neuronal factors, such as sensory nerves.
2-4-2. Humoral Factors PGs are synthesized from arachidonic acid by constitutive cyclooxygenase (COX-1), which is expressed by epithelial and endothelial cells of the gastric mucosa. Inhibition of COX-1 by aspirin or indomethacin results in mucosal damage and enhances the injurious action of strong irritants such as 100% ethanol. 37) The possibility that the level of gastric mucosal PGs is increased by certain substances present in the gastric lumen, either naturally or following intragastric administration of so-called "mild irritants," has also been explored. Since the protection resulting from mild irritants is eliminated to near completion by pretreatment with indomethacin, it was concluded that mild irritants protect the gastric mucosa by stimulating both COX-1 and the release of PGs in the stomach. 38) In contrast, COX-2 is characterized by rapid inducibility in response to various proinflammatory stimuli, such as mitogens, hormones, and cytokines, and has been thought to be responsible for PG production at inflammatory sites. 39) Recently, Yamamoto et al. 40) reported that 20 mM of taurocholate induced adaptive cytoprotection for over 5 h in rat stomachs against 0.6 M HCl. Based on evidence that later phase protection was inhibited by both NS-398, a selective COX-2 inhibitor, and indomethacin, Yamamoto concluded that later phase protection is mediated by PGs produced by both COX-1 and COX-2. Consequently, PGs derived from both COX-1 and COX-2 are considered to contribute to mucosal protection. Endogenous PGs have various functions in the stomach, i.e. enhancement of mucous-alkaline secretions, 41, 42) regulation of mucosal blood flow, 43) and inhibition of gastric motility. 36) Accordingly, PGs appear to contribute to cytoprotection via regulation of functional defensive factors. NO is synthesized from amino acid L-arginine by the enzyme NO synthase (NOS). Two types of NOS have been identified. 44) One of them, constitutive NOS (cNOS), is expressed under normal conditions; the NO released by this enzyme acts as a transduction mechanism underlying several physiological responses. 44) The other type of NOS, referred to as inducible NOS (iNOS), is not constitutively expressed and is only induced by certain cytokines, such as lipopolysaccharide (LPS) and tumor necrosis factor-alpha. 45) The NO released by iNOS is considered to act as a cytotoxic molecule against invading microorganisms and tumor cells. 46) It is likely, however, that this NO has other biological actions, to include pathological vasodilatation and tissue damage. 38) Wallace et al. 28) reported that NO-releasing agents, such as nitroglycerin and sodium nitorprusside, inhibited gastric mucosal hemorrhagic damage induced by 50 mM HCl or 70% ethanol. Since non-selective NOS inhibitors, such as N G -nitro-L-arginine (L-NA), and L-NAME, prevent the cytoprotective action of mild irritants, it was considered that NO produced by NOS plays a role in maintaining mucosal integrity. 28) NO is also known to regulate mucus/alkaline secretion, gastric motility, and microcirculation. [47] [48] [49] Accordingly, the cytoprotective effect of NO might be related to modulation of functional defensive factors.
Glutathione (GSH), a ubiquitous thiol, is involved in many cellular functions 50) and is considered to be involved in the maintenance of mucosal integrity. Indeed, it was reported that the cytoprotective action of certain drugs was attenuated by SH blockers, such as N-ethylmaleimide (NEM) or diethylmareate (DEM). 51, 52) In the anti-oxygenated mechanism of the gastric mucosa, GSH enhances resistance against oxidative stress by scavenging superoxide and preventing irreversible auto-oxidation of protein SH-groups.
53)
2-4-3. Neuronal Factors
In addition to PGs and NO, capsaicin-sensitive sensory neurons also contribute to mucosal protection.
30) It was reported that topical application of capsaicin resulted in neuronal activation and release of neuropeptides, such as substance P, calcitonin gene-related peptide (CGRP), and neurokinin. 31, 54) The functional ablation of sensory nerves can be achieved by administration of a large dose of capsaicin. 54, 55) Following studies demonstrated that sensory ablation aggravated mucosal lesions induced by necrotizing agents, the importance of sensory nerves in mucosal protection was documented. The topical administration of capsaicin causes hyperemic responses in gastric mucosa, but such a response is inhibited by sensory ablation, suggesting that sensory neurons regulate mucosal blood flow. 35) Given the above, many factors, such as PGs, NO, capsaicin-sensitive sensory neurons, and gastric motility, appear to be involved in adaptive cytoprotection induced by mild irritants. It was speculated that PGs, NO, and sensory nerves affect each other. In fact, it was reported that NO activates COX and enhances PG synthesis. 56) Furthermore, there are reports indicating that NO is an essential mediator of the gastric-protective effect of peripheral CGRP contained in capsaicin-sensitive afferent nerves. 57, 58) It was no surprise that recent studies demonstrated that gastric mucosal blood flow is regulated by PGs, NO, and sensory nerves. 59) 
THE ROLE OF HEAT SHOCK PROTEINS IN INTRA-CELLULAR DEFENSE
In various kinds of cells, a phenomenon similar to gastric adaptive cytoprotection is observed. When various cells such as HeLa cells were treated with non-lethal heat shock (about 42°C), the cells acquired tolerance against subsequent lethal heat shock (about 45°C), 60, 61) a phenomenon called "thermotolerance." Since this phenomenon is highly related to HSP synthesis, 62) HSPs have also been considered to contribute to adaptive cytoprotection in the gastrointestinal mucosa. Accordingly, HSPs, especially HSP70, are implicated as intracellular factors integral in the defense mechanism of gastrointestinal mucosa.
3-1. Expression of HSPs in Gastrointestinal Tract
It was known that major HSPs are induced in the digestive tract by various treatments. Even in cultured gastric mucosal cells, ethanol and H 2 O 2 , as well as heat shock, induce major HSPs. 63, 64) Interestingly, certain mucosal protective drugs, such as geranylgeranylacetone and rebamipide, were found to induce HSPs in cultured gastric mucosal cells isolated from guinea pigs and rabbits, suggesting that HSPs are involved in mucosal protection following adminstration of such drugs. 65, 66) In an in vivo study, it was reported that HSPs were induced by water-immersion restraint (WIR) stress, hyperthermia, and mucosal protective drugs, but the type of induced HSPs appears to differ depending on both the stimulation and the organs involved.
3-2. HSPs and Gastric Mucosal Protection Nakamura et al. 63) was the first who indicated that cells inducing HSPs by heat shock treatment resist 7.5% ethanol (a lethal concentration) in cultured guinea pig gastric mucosal cells. Accordingly, even in cultures, it has been suggested that HSPs participate in cytoprotection. Nonetheless, since cytoprotection observed in vivo could be explained by functional changes, such as increased microcirculation or inhibited gastric motility, it has been considered that the involvement of HSPs in cytoprotection might only be a phenomenon observed in culture. In order to answer such a question, several investigators attempted to examine the involvement of HSPs in gastrointestinal mucosal protection in vivo.
In rat stomachs, a positive relationship between HSP induction and mucosal protection was reported. Itoh and Noguchi 67) reported that pretreatment with whole body heating prevents gastric lesions induced by WIR stress in rats. It was found that a high level of HSP70 expression was observed after WIR stress in animals pretreated with hyperthermia, as compared with stress alone.
Hirakawa et al. 65) demonstrated that oral administration of geranylgeranylacetone (GGA), an antiulcer drug, rapidly induced HSP60, HSP70, HSC70, and HSP90 in the gastric mucosa of normal rats. Furthermore, it was found that GGA also enhanced the induction of such HSPs in rat gastric mucosa exposed to WIR stress and suppressed stress ulcer formation. Based upon such results, Hirakawa suggested that drugs that induce HSPs positively contribute to gastric mucosal defense against stressful situations.
Konturek et al. 68) reported that gastric mucosa increases its resistance to damage caused by aspirin during repeated administration of aspirin. Jin et al. 69) observed that the increase in HSP (mainly HSP70) expression correlated with mucosal resistance that observed after repeated administration of aspirin. It is most likely that gastric mucosa with increased HSPs acquires tolerance to necrotizing stimuli.
3-3. HSPs and Intestinal Mucosal Protection
In contrast to the stomach, in the small intestine and colon, the induction of HSPs does not always result in mucosal protection. Stojadinovic et al. 70) reported that induction of HSP70 in rats by whole body hyperthermia (41.5-42°C, 20 min) protected the small intestines from ischemia/reperfusion-induced damage. Jin et al. 71) examined the effect of pre-induction of HSPs caused by whole body hyperthermia (42.5°C, 20 min) on indomethacin-induced small intestinal mucosal lesions in rats. The expression of HSP70 and HSC70, but not HSP60, was significantly increased 6-9 h after hyperthermia. Despite preinduction of such HSPs, intestinal mucosa was not protected against indomethacin. Based on such findings, Jin concluded that the expressed HSPs had no cytoprotective effect on the small intestine against indomethacin. In contrast, Sasahara et al. 72) indicated that either WIR stress for 24 h or thyrotropin-releasing hormone (TRH, 20 mg/kg, i.p.) significantly increased expression of HSP60 in the small intestinal mucosa of rats, but had no effect on HSP70 and HSP90 expression. Despite increased expression of HSP60, the small intestine was not protected against acetic acid-induced damage.
It is of interest that whole body hyperthermia significantly increased expression of HSP60, HSP70, and HSP90 in rat colons. While colonic mucosal protection against acetic acid correlated well with induction of HSP70 and HSP90, the protection was unrelated to HSP60. 73) Iwabuchi et al. 74) reported that significant preinduction of HSP60 by TRH did not protect rat colonic mucosa from acetic acid-induced lesions. Such results clearly indicate that increased expression of HSP60, regardless of the stimuli, affords no protective effect for the colonic mucosa.
Taken altogether, the role of HSPs in gastrointestinal mucosal defense appears to differ depending on the location involved and the proteins induced. Except for the report by Jin et al., 71) the induction of HSPs, particularly HSP70, appears to result in mucosal protection in the gastrointestinal tract. HSP70 is one of the most inducible HSPs in response to stressful situations.
75) HSP70 appears to be closely linked to cytoprotection for thermal injuries. 76) HSP70 is known to repair partially damaged proteins though its molecular chaperone activity. [11] [12] [13] Accordingly, it is suggested that HSP70 contributes to protection of the gastrointestinal mucosa against various noxious factors. Studies examining the relationship between HSP induction and mucosal protection are listed in Table 2 . Lee et al. 77) reported that pretreatment with indomethacin clearly lowered the temperature threshold of heat shock transcription factor-1 (HSF-1) activation in HeLa cells. A complete heat shock response was attained at temperatures (40 and 41°C) that are insufficient without pretreatment. Ethridge et al. 78) recently proved that overexpression of COX-2 by transfected cDNA inhibited expression of HSP70, HSP70 mRNA, and activation of HSF-1 in response to heat shock in rat intestinal epithelial cells. Such inhibition was antagonized by a selective COX-2 inhibitor, NS-398. Subsequently, Ethridge stated that PGs derived from COX-2 might be associated with HSP70 induced by heat shock, suggesting an inversible relationship between COX-2 expression and HSP70 induction. Soncin and Calderwood 79) showed that while 3 mM of aspirin clearly activated HSF-1 in human monocytes, 1 mM of aspirin, which inhibits COX activity, did not activate HSF-1. Accordingly, it was concluded that HSF-1 activation by aspirin might be based on the direct action of aspirin rather than inhibition of COX activity. Considering that indomethacin and aspirin enhance the heat shock response, mucosal adaptation by repeated administration of aspirin might be explained by such phenomenons.
RELATIONSHIP BETWEEN HSPs AND HUMORAL FACTORS
4-1. HSPs and PGs
4-2. HSPs and NO
Certain reports have dealt with the induction of HSPs and NOS in organs and cells other than those of the gastrointestinal tract. Wong et al. 80) reported that the expression of iNOS induced by interleukin-1b was inhibited by preinduced HSP70 at the transcriptional level in rat pulmonary artery smooth muscle cells. Furthermore, Hauser et al. 81) also reported that sodium arsenite, known to induce HSP70 in the mesenteric artery, lung, and liver, significantly attenuated hypotension and iNOS mRNA expression induced by endotoxin-challenges in rats. They explained their findings by suggesting that enhanced expression of HSP70 might inhibit expression of iNOS mRNA, leading to the reduced NO levels in the blood.
Byrne and Hanson 82) found that S-nitroso-N-acetyl-penicillamine, an NO donor, induced HSP70 in a concentration dependent manner in cultured guinea pig gastric mucosal cells. Given the above, it is suggested that HSP70 is involved in negative feed back regulation of NO synthesis.
Shah et al. 83) indicated that geldanamycin, a specific inhibitor of HSP90 signaling, attenuated acethylcholine-dependent vasodilatation in rat mesentery, but did not affect vasodilatation in response to sodium nitroprusside. Based on such findings, Shah suggested that HSP90 could act as a signaling mediator of NO-dependent responses in mesenteric circulation. Quite recently, Bucci et al. 84) reported that geldanamycin has an antiinflammatory effect in mice by inhibiting the function of HSP90. Considering Shah's report, we hypothesized that constitutively expressed HSPs contribute to mucosal protection through regulating the activity of functional proteins, such as COX and NOS, rather than inducing such proteins.
In order to elucidate such a hypothesis, we examined the interaction between HSC70 and COX-1 or HSC70 and nNOS in rat gastric mucosa following treatment with 20% ethanol or 20 mM taurocholate/50 mM HCl (HCl/taurocholate) as mild irritants. We first confirmed the protective effect of 20% ethanol and HCl/taurocholate on gastric mucosa against 100% ethanol (Figs. 1A, B) . PGE 2 and NOx in the gastric juice in pylorus-ligated rats was found to increase 30 min after treatment with HCl/taurocholate. In contrast, 20% ethanol was found to increase PGE 2 , while exerting no effect on NOx (Fig. 1C) . HSC70, HSP70, COX-1 and nNOS levels in the gastric mucosa were found not to change before and after administration of 20% ethanol (Fig. 1D, unpublished  data) . Using an immunoprecipitation method, we found that HSC70 clearly coprecipitated COX-1 and nNOS. Such results suggest that HSC70 might bind partially damaged COX-1 and nNOS in response to ethanol in order to repair the mucosa or protect from a subsequent strong irritant. In HCl/taurocholate-treated rats, however, no interaction of HSC70 with COX-1 or nNOS in the gastric mucosa or induction of other protein was observed. Such findings suggest that interaction of HSC70 with functional proteins was not involved in adaptive cytoprotection in the case of HCl/taurocholate. It is possible that constitutively expressed HSPs, such as HSC70, protect key enzymes involved in cytoprotection through their molecular chaperone activity. Nonetheless, HSP involvement in cytoprotection might differ depend on the type of mild irritant. A possible mechanism for HSP involvement in adaptive cytoprotection in the gastrointestinal mucosa is diagrammed in Fig. 2 .
ROLE OF HSPs IN THE HEALING OF CHRONIC GASTRIC ULCERS
In general, the healing of gastroduodenal ulcers resembles the process observed in wound healing. Accordingly, studies of wound healing are considered to be useful for understanding the various problems of ulcer healing. Wound healing can be divided into three consecutive and overlapping phases: 1) inflammation, 2) organization of the inflammatory exudate, which leads to reepithelization, granulation tissue formation, and angiogenesis, and 3) remodeling of the extracellular matrix. 85) Laplante et al. 86) reported that several HSPs in the neoepidermis are related to the proliferation, migration, and differentiation states of keratinocytes within the wound. Nonetheless, no study has dealt with HSP expression during ulcer healing.
5-1. Acetic Acid Ulcer Models As an experimental chronic ulcer model, we used type III acetic acid ulcers, which we devised by modifying the standard acetic acid ulcer models established by Takagi et al. 87) Briefly, the method consists of topical application of a small amount of acetic acid solution to the gastric mucosal surface of rats, by injecting the solution into an area clamped with ring forceps. 88) Since the acid solution is allowed to touch both the anterior and posterior wall, two ulcers are induced at the same time, which are called kissing ulcers (Fig. 3) . Using such acetic acid ulcer models, many studies were performed dealing with the mechanism of ulcer healing. Such studies led to the documentation of the involvement of regeneration and migration of epithelial cells in the ulcer margin, 89) blood flow, 90) and angiogenesis. 91, 92) Furthermore, it has been demonstrated that such events are regulated by a complilcated assortment of various humoral factors, such as growth factors, cytokines, PGs, NO, and sensory neurons. [93] [94] [95] [96] Besides wound healing, our group 97) previously demonstrated that the granulation tissue from the ulcer base contracts in response to PGs. Since ulcer healing was accelerated when the animals were fed a liquid diet for prevention of stomach distension, 98) we concluded that contraction of the ulcer base might be involved in 6 Vol. 24, No. 1 ulcer healing.
In contrast, several factors are known to delay ulcer healing. The retardative effect of luminal acid is documented by many studies using anti-secretory drugs, such as H 2 -receptor antagonist 88, 99) and proton pump inhibitors. 99, 100) Nonsteroidal anti-inflammatory drugs and steroidal anti-inflammatory drugs are also known to delay ulcer healing. 94, 101, 102) Our group revealed that ulcers in which healing was delayed by repeated administration of indomethacin become intractable.
103)
5-2. Ulcer Healing and HSPs
Recently, we examined the expression of HSPs during the healing of kissing ulcers in rats. 104) We found that HSC70 was expressed at a high level in both the normal mucosa and the ulcerated tissue. On the other hand, the level of HSP70 expression in the normal mucosa was quite low, but was markedly higher in the ulcer base at the time of ulcer development. HSP70 expression in the ulcer margin was observed 14 d after ulceration, but not after only 7 d. We previously reported that the healing process of gastric ulcers is divided into two phases: an early phase, which has a rapid healing rate that depends on the contraction of the ulcer base; and a late phase, which has a slow healing rate that depends on the contraction of the ulcer base and mucosal regeneration. 98) In the case of wound healing, HSP70 is expressed in proliferating cells during reepithelization, 79) thus it is thought that HSP70 expression in the ulcer margin is also linked to regeneration of ulcerated mucosa. Since severe inflammation occurs in the ulcer base, key factors for ulcer healing include growth factors, cytokines, COX-2 and iNOS. Accordingly, HSP70 induced in the ulcer base might either contribute to de novo synthesis of proteins or regulate the activity of key enzymes for ulcer healing through molecular chaperone activity. HSP47 is a 47-kDa stress protein that specifically binds to collagen. 105) Formation of mature granulation tissue is important for a high quality of ulcer healing. In particular, collagen biosynthesis represents an essential step for granulation tissue formation. Consequently, it remains possible that HSP47 plays an important role in ulcer healing through collagen biosynthesis. As was expected, we found that HSP47 was also expressed in the ulcer base at the time of ulcer development. HSP47 expression in the ulcer base decreased with ulcer healing, but a higher level was observed even 14 d after ulceration. Such a result suggests that HSP47 might be involved in ulcer healing by playing a role in collagen biosynthesis.
Although the above findings implicate the involvement of multiple factors, including HSPs, in the mechanism of ulcer healing (Fig. 4) , additional investigation is warranted. 
HELICOBACTOR PYLORI AND HSPs
Helicobacter pylori (H. pylori), first discovered by Marshall and Warren, 106) is recognized as a causal factor of gastritis, ulcers, and cancer. Indeed, it was demonstrated that H. pylori infection could induce acute damage, ulcers, and cancer in Mongolian gerbils. [107] [108] [109] It remains unknown whether or not HSPs, most probably expressed in the gastric mucosa, play a role in the pathogenic mechanism of H. pylori-induced damage. Interestingly, it was suggested that HSP60 from H. pylori is associated with adhesion of the bacteria to gastric epithelial cells. Yamaguchi et al. 110) indicated that the antibody against HSP60 from H. pylori inhibited the adhesion of H. pylori to MKN45, MKN28, and KATO III cells. Yamaguchi also reported that HSP60 from H. pylori induces IL-8 secretion from gastric cell lines. 111) Given such findings, it is suggested that HSP60 from HP is an important virulence factor associated with chronic gastric inflammation following HP infection.
CONCLUSION
The above results clearly demonstrate that intracellular factors, including HSPs, play a crucial role in the defense of the gastric mucosa against various necrotizing materials, as well as affecting functional, humoral, and neuronal factors. The underlying mechanism might involve interaction of HSPs and functional proteins, such as COX and NOS, which are expressed in normal or damaged cells. With the help of HSPs, such functional proteins secrete prostaglandins and NO for the maintenance of mucosal integrity and repair of acute mucosal damage, enhancing ulcer healing.
